A detailed history of Eventide Asset Management, LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 332,277 shares of DYN stock, worth $7.96 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
332,277
Previous 485,000 31.49%
Holding current value
$7.96 Million
Previous $17.1 Million 30.27%
% of portfolio
0.21%
Previous 0.3%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$31.94 - $47.04 $4.88 Million - $7.18 Million
-152,723 Reduced 31.49%
332,277 $11.9 Million
Q2 2024

Aug 13, 2024

BUY
$23.65 - $35.63 $11.5 Million - $17.3 Million
485,000 New
485,000 $17.1 Million

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.24B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.